Eversept Partners’s Cullinan Therapeutics CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
Eversept Partners's CGEM Position: Q3 2021 in Review
Eversept Partners sold out of Cullinan Therapeutics (CGEM) in Q3 2021, closing a stake of 163,880 shares — an estimated $4.22M sold.
Eversept Partners first reported a position in CGEM in Q2 2021 and held it in 1 quarter. The position peaked at $4.22M in Q2 2021. 66 funds tracked by Wall St. Rank hold CGEM as of Q3 2021.
- Eversept Partners reported no remaining Cullinan Therapeutics position as of Q3 2021 after selling out during the quarter.
- Eversept Partners sold 163,880 Cullinan Therapeutics shares in Q3 2021, an estimated $4.22M.
- Eversept Partners first reported a position in Cullinan Therapeutics in Q2 2021 and held it in 1 quarter.
- Eversept Partners's Cullinan Therapeutics position peaked at $4.22M in Q2 2021.
- 66 funds tracked by Wall St. Rank held Cullinan Therapeutics as of Q3 2021.
Based on Eversept Partners's 13F filing for Q3 2021, filed 15 Nov 2021.